5 drug(s) with this reaction
9,802 total reports
Migraine has been reported as an adverse reaction across 5 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 9,802 adverse event reports mention migraine in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with migraine, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have migraine listed in their FDA adverse event reports, sorted by report count:
In addition to migraine, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
5 drug(s) manufactured by Amgen Inc have migraine listed in their FDA adverse event reports: ERENUMAB-AOOE, Otezla, APREMILAST, ROMIPLOSTIM, IVABRADINE.
There are a combined 9,802 reports of migraine across 5 Amgen Inc drug(s) in the FDA adverse event database.